Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stutzman

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Cancer|January 15, 1982
The influence of histologic type on the incidence and duration of response in non-Hodgkin's lymphomaR Herrmann, M Barcos, L Stutzman, et al.
Journal of Medical Virology|January 1, 1977
Pharmacologic effects of polyinosinic-polycytidylic acid in manA I Freeman, N Al-Bussam, J A O'Malley, et al.
Cancer|June 15, 1981
The influence of histologic type on survival in non-Hodgkin's lymphomaM Barcos, R Herrmann, J W Pickren, et al.
Cancer Treatment Reports|January 1, 1982
Combinations of methotrexate (COP or CHOP) in the treatment of previously untreated and treated lymphomasG A Gomez, L Stutzman, H Moayeri, et al.
Medical and Pediatric Oncology|January 1, 1976
Hodgkin's disease in childrenN K Shah, A I Freeman, M Friedman, et al.
The American Journal of Cardiology|January 15, 1984
Arterial complications of attempted Swan-Ganz insertionG M Silver, S A Bogerty, R M Hayashi, et al.
Cancer|April 1, 1979
Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin's disease: a Cancer and Acute Leukemia Group B studyB Hoogstraten, O Glidewell, J F Holland, et al.
Pharmacogenomics|March 4, 2021
Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patientsIna Liko, Yee Ming Lee, Danielle L Stutzman, et al.
The American Journal of Medicine|August 1, 1984
Staging laparotomy and splenectomy in early Hodgkin's disease. No therapeutic benefitG A Gomez, P A Reese, H Nava, et al.
Neuroscience|November 24, 2007
Prostaglandins are necessary and sufficient to induce contextual fear learning impairments after interleukin-1 beta injections into the dorsal hippocampusA M Hein, D L Stutzman, S T Bland, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Cancer|January 15, 1982
The influence of histologic type on the incidence and duration of response in non-Hodgkin's lymphomaR Herrmann, M Barcos, L Stutzman, et al.
Journal of Medical Virology|January 1, 1977
Pharmacologic effects of polyinosinic-polycytidylic acid in manA I Freeman, N Al-Bussam, J A O'Malley, et al.
Cancer|June 15, 1981
The influence of histologic type on survival in non-Hodgkin's lymphomaM Barcos, R Herrmann, J W Pickren, et al.
Cancer Treatment Reports|January 1, 1982
Combinations of methotrexate (COP or CHOP) in the treatment of previously untreated and treated lymphomasG A Gomez, L Stutzman, H Moayeri, et al.
Medical and Pediatric Oncology|January 1, 1976
Hodgkin's disease in childrenN K Shah, A I Freeman, M Friedman, et al.
The American Journal of Cardiology|January 15, 1984
Arterial complications of attempted Swan-Ganz insertionG M Silver, S A Bogerty, R M Hayashi, et al.
Cancer|April 1, 1979
Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin's disease: a Cancer and Acute Leukemia Group B studyB Hoogstraten, O Glidewell, J F Holland, et al.
Pharmacogenomics|March 4, 2021
Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patientsIna Liko, Yee Ming Lee, Danielle L Stutzman, et al.
The American Journal of Medicine|August 1, 1984
Staging laparotomy and splenectomy in early Hodgkin's disease. No therapeutic benefitG A Gomez, P A Reese, H Nava, et al.
Neuroscience|November 24, 2007
Prostaglandins are necessary and sufficient to induce contextual fear learning impairments after interleukin-1 beta injections into the dorsal hippocampusA M Hein, D L Stutzman, S T Bland, et al.
Pageof 7